ResearcherNingbo UniversityActive in the last 2 years

Siming Zheng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9259-0954; OpenAlex author ID A5102851264, A5137551168. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 3

Papers, trials and grants by year

2024: 1 paper · 2025: none · 2026: 1 paper

Papers 2

Advances in deciphering intratumoral versus peritumoral heterogeneity of infiltrating lymphocytes in pancreatic cancer: a spatial perspective. Last author DOI 10.1016/j.tranon.2026.102823 ↗
LncRNA MACC1-AS1 induces gemcitabine resistance in pancreatic cancer cells through suppressing ferroptosis. Last author DOI 10.1038/s41420-024-01866-y ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ke Zhao · 1 shared paper, 2026 · strength 0.39
- Paper Advances in deciphering intratumoral versus peritumoral heterogeneity of infiltrating lymphocytes in pancreatic cancer:… DOI 10.1016/j.tranon.2026.102823 ↗
Bin Zhang · 1 shared paper, 2024 · strength 0.21
- Paper LncRNA MACC1-AS1 induces gemcitabine resistance in pancreatic cancer cells through suppressing ferroptosis. DOI 10.1038/s41420-024-01866-y ↗
Jiyun Zhu · 1 shared paper, 2024 · strength 0.21
- Paper LncRNA MACC1-AS1 induces gemcitabine resistance in pancreatic cancer cells through suppressing ferroptosis. DOI 10.1038/s41420-024-01866-y ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.